C07F 9/091
With hydroxyalkyl compounds with further substituents on alkyl
Official title: {with hydroxyalkyl compounds with further substituents on alkyl}
C07F9/091 (With hydroxyalkyl compounds with further substituents on alkyl) appears on 979 US grants and 777 published applications in this corpus.
Search patents in C07F- Granted patents
- 979
- Published applications
- 777
- Assignees
- 574
- Inventors
- 2,173
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 15 | 0 |
| 1977 | 22 | 0 |
| 1978 | 15 | 0 |
| 1979 | 13 | 0 |
| 1980 | 14 | 0 |
| 1981 | 11 | 0 |
| 1982 | 8 | 0 |
| 1983 | 11 | 0 |
| 1984 | 6 | 0 |
| 1985 | 20 | 0 |
| 1986 | 13 | 0 |
| 1987 | 17 | 0 |
| 1988 | 16 | 0 |
| 1989 | 23 | 0 |
| 1990 | 12 | 0 |
| 1991 | 13 | 0 |
| 1992 | 14 | 0 |
| 1993 | 17 | 0 |
| 1994 | 9 | 0 |
| 1995 | 17 | 0 |
| 1996 | 15 | 0 |
| 1997 | 17 | 0 |
| 1998 | 21 | 0 |
| 1999 | 25 | 0 |
| 2000 | 11 | 0 |
| 2001 | 24 | 5 |
| 2002 | 25 | 23 |
| 2003 | 25 | 28 |
| 2004 | 19 | 25 |
| 2005 | 12 | 29 |
| 2006 | 16 | 22 |
| 2007 | 21 | 31 |
| 2008 | 14 | 29 |
| 2009 | 14 | 39 |
| 2010 | 21 | 44 |
| 2011 | 32 | 34 |
| 2012 | 36 | 39 |
| 2013 | 36 | 34 |
| 2014 | 26 | 21 |
| 2015 | 23 | 27 |
| 2016 | 22 | 26 |
| 2017 | 17 | 40 |
| 2018 | 29 | 41 |
| 2019 | 40 | 45 |
| 2020 | 30 | 35 |
| 2021 | 26 | 35 |
| 2022 | 18 | 29 |
| 2023 | 26 | 31 |
| 2024 | 20 | 21 |
| 2025 | 24 | 22 |
| 2026 | 8 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compound18 Aug 2026US 12,709,627 B2Sumitomo Chemical Company, Limited
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid19 May 2026US 12,629,421 B2Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Ionizable cationic lipids21 Apr 2026US 12,606,773 B2Akagera Medicines, Inc.
- Ultra bright dimeric or polymeric dyes17 Mar 2026US 12,577,403 B2Sony Group Corporation
- Long-lived gadolinium based tumor targeted imaging and therapy agents3 Mar 2026US 12,564,635 B2Wisconsin Alumni Research Foundation
- Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents8 Oct 2026US 2026/0306634 A1Wisconsin Alumni Research Foundation
- Compounds and processes for the synthesis of sphingomyelins27 Aug 2026US 2026/0250305 A1Abionyx Pharma SA
- Compounds and formulations for protective coatings6 Aug 2026US 2026/0223872 A1Apeel Technology, Inc.
- Methods and compositions for treatment of obesity and diseases associated with fat cell enlargement6 Aug 2026US 2026/0224530 A1MelliCell, Inc.
- Helper lipids for nucleic acid delivery6 Aug 2026US 2026/0224688 A1Sanofi Pasteur Limited
Most cited
By later US patents
- Phosphoramidate and phosphorothioamidate oligomeric compounds271US 5,637,684 AIsis Pharmaceuticals, Inc. · 1997
- Biologically reversible phosphate and phosphonate protective gruops163US 4,968,788 ABoard of Regents, The University of Texas System · 1990
- 1,3-propane diol esters and ethers and methods for their use in drug delivery162US 6,555,700 B1Scotia Holdings PLC · 2003
- Biologically reversible phosphate and phosphonate protective groups158US 4,816,570 ABoard of Regents, The University of Texas System · 1989
- Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof152US 5,985,856 AUniversity of Kansas · 1999